NO20020929D0 - New interferon-beta like molecules - Google Patents

New interferon-beta like molecules

Info

Publication number
NO20020929D0
NO20020929D0 NO20020929A NO20020929A NO20020929D0 NO 20020929 D0 NO20020929 D0 NO 20020929D0 NO 20020929 A NO20020929 A NO 20020929A NO 20020929 A NO20020929 A NO 20020929A NO 20020929 D0 NO20020929 D0 NO 20020929D0
Authority
NO
Norway
Prior art keywords
beta
molecules
new interferon
interferon
new
Prior art date
Application number
NO20020929A
Other languages
Norwegian (no)
Other versions
NO20020929L (en
Inventor
Anders Hjelholt Pedersen
Hans Thalsgaard Schambye
Kim Vilbour Andersen
Claus Bornaes
Poul Baad Rasmussen
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Aps filed Critical Maxygen Aps
Publication of NO20020929D0 publication Critical patent/NO20020929D0/en
Publication of NO20020929L publication Critical patent/NO20020929L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20020929A 1999-08-27 2002-02-26 Novel interferon beta-like molecules NO20020929L (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA199901197 1999-08-27
US16078299P 1999-10-21 1999-10-21
DKPA199901691 1999-11-26
DKPA200000194 2000-02-07
DKPA200000363 2000-03-07
DKPA200000642 2000-04-14
PCT/DK2000/000471 WO2001015736A2 (en) 1999-08-27 2000-08-25 Interferon-beta conjugates

Publications (2)

Publication Number Publication Date
NO20020929D0 true NO20020929D0 (en) 2002-02-26
NO20020929L NO20020929L (en) 2002-04-25

Family

ID=27545189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020929A NO20020929L (en) 1999-08-27 2002-02-26 Novel interferon beta-like molecules

Country Status (14)

Country Link
EP (1) EP1328295A2 (en)
JP (1) JP2003527090A (en)
KR (1) KR20020034181A (en)
CN (1) CN1501815A (en)
AU (1) AU6687000A (en)
BR (1) BR0013638A (en)
CA (1) CA2380760A1 (en)
CZ (1) CZ2002521A3 (en)
HU (1) HUP0302674A2 (en)
IL (1) IL147581A0 (en)
MX (1) MXPA02001969A (en)
NO (1) NO20020929L (en)
SK (1) SK2942002A3 (en)
WO (1) WO2001015736A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2599503T (en) * 1998-10-16 2017-06-26 Biogen Ma Inc. Polymer conjugates of interferon beta-1A and uses thereof
CN100480266C (en) 1998-10-16 2009-04-22 拜奥根Idec马萨诸塞公司 Interferon-beta fusion proteins and uses
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
EP1334128A2 (en) * 2000-11-02 2003-08-13 Maxygen Aps New multimeric interferon beta polypeptides
MXPA03007619A (en) * 2001-02-27 2003-12-04 Maxygen Aps New interferon beta-like molecules.
AU2002254174A1 (en) * 2001-03-13 2002-09-24 Vical Incorporated Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases
KR100511749B1 (en) * 2001-11-06 2005-09-02 선바이오(주) Modified interferon-beta, and chemically modified conjugates thereof
EP3669887A1 (en) 2002-01-18 2020-06-24 Biogen MA Inc. Polyalkylene polymer compounds and uses thereof
AU2003254641A1 (en) * 2002-08-28 2004-03-19 Maxygen Aps Interferon beta-like molecules for treatment of cancer
EA008866B1 (en) 2002-12-26 2007-08-31 Маунтин Вью Фамэсьютикэлс, Инк. POLYMER CONJUGATES OF INTERFERON-β, PHARMACEUTICAL PRODUCTS BASED THEREON AND METHOD FOR THE PRODUCTION THEREOF
PT1666496E (en) 2003-08-25 2014-06-24 Toray Industries Interferon-beta composite
EP1674113A1 (en) * 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
WO2008020968A2 (en) * 2006-08-08 2008-02-21 Novartis Ag Recombinant interferon-beta with enhanced biological activity
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CL2008002399A1 (en) * 2007-08-16 2009-01-02 Pharmaessentia Corp Substantially pure conjugate having a polymeric portion, a protein portion (interferon alpha 2b) and an aliphatic binder of 1 to 10 carbon atoms, useful in the treatment of hepatitis b or c.
CN104043112B (en) * 2014-07-01 2016-03-30 哈药集团生物工程有限公司 A kind of ointment pharmaceutical composition containing recombinanthumaninterferonα-2b (pseudomonas)
SI3215193T1 (en) 2014-11-06 2024-02-29 Pharmaessentia Corporation Dosage regimen for pegylated interferon
WO2017194783A1 (en) * 2016-05-13 2017-11-16 Orionis Biosciences Nv Targeted mutant interferon-beta and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
DE3676670D1 (en) * 1985-06-26 1991-02-07 Cetus Corp SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS BY POLYMER CONJUGATION.
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
IL113280A (en) * 1994-04-12 2004-12-15 Res Dev Foundation Composition for treating auto-immune diseases using type one interferons
US5738846A (en) * 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
EP1017794A1 (en) * 1997-02-06 2000-07-12 Novo Nordisk A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
BR9812267B1 (en) * 1997-07-14 2013-11-26 Recombinant Growth Hormone.
LT2599503T (en) * 1998-10-16 2017-06-26 Biogen Ma Inc. Polymer conjugates of interferon beta-1A and uses thereof

Also Published As

Publication number Publication date
HUP0302674A2 (en) 2003-11-28
KR20020034181A (en) 2002-05-08
CA2380760A1 (en) 2001-03-08
AU6687000A (en) 2001-03-26
WO2001015736A2 (en) 2001-03-08
NO20020929L (en) 2002-04-25
JP2003527090A (en) 2003-09-16
IL147581A0 (en) 2002-08-14
CN1501815A (en) 2004-06-02
BR0013638A (en) 2002-05-14
SK2942002A3 (en) 2002-08-06
CZ2002521A3 (en) 2002-05-15
MXPA02001969A (en) 2003-07-21
WO2001015736A3 (en) 2003-05-22
EP1328295A2 (en) 2003-07-23

Similar Documents

Publication Publication Date Title
NO20014518L (en) New connections
DK1202994T3 (en) New connections
DK1676845T3 (en) New quinazoline derivatives
NO20021436L (en) New connections
DE60044873D1 (en) ORIENTED BIOPOLYMERMEMBRANES
NO20020810D0 (en) New phenylpiperazines
NO20020929D0 (en) New interferon-beta like molecules
DK1237857T3 (en) New Phenalkyloxyphenyl Derivatives
NO20015383D0 (en) New connections
NO20022606D0 (en) Pharmaceutical combinations
DE60040583D1 (en) TURNTABLE
NO20022564D0 (en) New androgens
NO20015374D0 (en) New connections
NO995945D0 (en) New connections
FI19992741A (en) Qualifying Hardware
DE60023419D1 (en) TURNTABLE
NO20014629L (en) New connections
NO20016273D0 (en) New connections
DE60028051D1 (en) MEDIA
IT246647Y1 (en) PERFECTED THERMOMANOMETER STRUCTURE
DE50000737D1 (en) GEARMOTOR
ITFI990054V0 (en) PERFECTED MUSIVE STRUCTURE
ITFI990104A3 (en) PERFECTED MUSIVE STRUCTURE
ES1045263Y (en) PERFECTED RASTREL
GT200000036A (en) NEW DIHYDROPIRIMIDINES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application